fda approved tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Eli Lilly seeks FDA approval

If tirzepatide is discontinued, some or all of the lost weight may be regained, given how the medication works to regulate appetite and glucose metabolism

At DrNewMed, we recognize that your weight loss journey is unique, and our Medical Weight Loss Programs featuring Semaglutide and Tirzepatide (Mounjaro) are designed to support your individual goals

Get started COVERAGE VARIES BY PLAN Medicare Advantage Plans Medicare Advantage (Part C) plans with prescription drug coverage (MA-PD) must follow the same federal exclusion for weight loss drugs, but coverage for the OSA indication varies significantly by plan

The process is straightforward and could save you up to 80% on brand-name and generic medications at more than 35,000 pharmacies across the country